Claireeeee personal page - To The Moon

Claireeeee

Claireeeee

No personal profile

1Follow

0Followers

0Topic

0Badge

2021-06-24

Yes

Sorry, the original content has been removed

2021-06-23

?

Sorry, the original content has been removed

2021-06-22

ok

Sorry, the original content has been removed

2021-06-22

good

Tesla’s Profitability and the Surprising Thing That Could Threaten It

2021-06-22

haha

Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries

2021-06-22

good

Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3585969981658298","uuid":"3585969981658298","gmtCreate":1622895601508,"gmtModify":1624326736666,"name":"Claireeeee","pinyin":"claireeeee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":121706702,"gmtCreate":1624491518006,"gmtModify":1703838063379,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"Yes&nbsp;","listText":"Yes&nbsp;","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121706702","repostId":"1167125957","repostType":4,"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123116243,"gmtCreate":1624411938882,"gmtModify":1703835852642,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/123116243","repostId":"1160611217","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120695608,"gmtCreate":1624320791604,"gmtModify":1703833284937,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"&nbsp;ok","listText":"&nbsp;ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120695608","repostId":"1164927223","repostType":4,"isVote":1,"tweetType":1,"viewCount":142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120698457,"gmtCreate":1624320707679,"gmtModify":1703833281698,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120698457","repostId":"1100861051","repostType":4,"repost":{"id":"1100861051","pubTimestamp":1624280482,"share":"https://ttm.financial/m/news/1100861051?lang=&edition=fundamental","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"Tesla’s Profitability and the Surprising Thing That Could Threaten It","url":"https://stock-news.laohu8.com/highlight/detail?id=1100861051","media":"The Street","summary":"Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, ","content":"<blockquote>\n Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n</blockquote>\n<p>The explosion in electric vehicle (EV) demand has served to vindicate the vision of Tesla’s&nbsp;(<b>TSLA</b>) -Get Report&nbsp;celebrity CEO Elon Musk. Indeed, the surge in demand for EVs has not only vindicated his foresight, but allowed his company to remain a market leader above late-coming competitors.</p>\n<p>However, while the company Musk leads as Technoking is no doubt a market leader, it has not solely cashed in by beating its competitors in terms of sales. Instead, a key to the company's recent turn to profitability has come from taking advantage of government incentives and selling the excess incentives it holds to these very same competitors. And now that many of these competitors are engaging more aggressively in EVs themselves, Tesla may soon find itself without many of these customers and, therefore, without a significant contributor to its profits.</p>\n<p><b>Raking in the Regulatory Credits</b></p>\n<p>The credits that Tesla has handsomely profited from are tradable credits offered by various governments around the world for zero-emission vehicles. The fact that they are tradable is crucial since this allows Tesla to sell the credits to other automakers who might not otherwise comply with emission standards without the use of these credits. The set-up allows Tesla to book the credits as purely additive to its top line, with the automakers buying these credits avoiding hefty fines from regulators.</p>\n<p>Per Tesla’s most recent 10-K filing, the company earned $1.58 billion from the sale of these credits in 2020, up from $594 million in the year prior and $419 million in 2018. The year-over -year jump notwithstanding, the credit sales might appear to be a paltry sum given the company’s $31.5 billion in total revenue in 2020. However, their nature as purely profit, in contrast to capital intensive auto manufacturing, means they have been a pivotal part of Tesla’s push towards profitability.</p>\n<p>Indeed, Tesla’s much-lauded $721 million profit in 2020, the very first profitable full year in its history, was clearly boosted over the top by the surge in regulatory credit sales. Had they remained consistent with the prior periods, the landmark year would have been left short of break-even, keeping up the company's trend of annual losses maintained since its inception.</p>\n<p>The trend has continued into 2021 as the company reported $518 million in revenues from credit salesin the first quarter, which boosted the company once again to a $438-million quarterly profit. While vehicle deliveries consistently catch the headlines, it's clear that the regulatory credits are buoying the automaker into the black.</p>\n<p><b>Competition Cuts Into Cash Flow</b></p>\n<p>The problem with the profit margin may be approaching faster than some have anticipated as well, with the increased entry of traditional automakers like Ford&nbsp;(<b>F</b>) -Get Report, General Motors&nbsp;(<b>GM</b>) -Get Report, and Stellantis STLA into the EV space.</p>\n<p>While much of the focus revolves around these companies’ threat to Tesla’s core auto sales, the popularity of Tesla among its devoted fans might sustain it amidst the hard-charging competition. As such, the trajectory of its sales, while now threatened by competent competition, remains somewhat murky at the moment.</p>\n<p>The question of regulatory credit impact is much more straightforward. If Tesla’s competitors are producing their own electric vehicles and fewer ICE autos, they have no need to spend so substantially on buying credits from Tesla.</p>\n<p>Per a Reuters report, Fiat Chrysler agreed to purchase $2.4 billion worth of emissions credits from Tesla from 2019 through 2021, likely accounting for a lion’s share of the roughly $2.2 billion recorded in total in credits sold in Tesla’s 2019 and 2020 10-K filings. However, after Fiat Chrysler merged with French automaker PSA Group in May to form Stellantis, this reliable revenue stream looks likely to fade.</p>\n<p>\"With the electrical technology that PSA brought to Stellantis, we will autonomously meet carbon dioxide emission regulations as early as this year,\" Stellantis CEO Carlos Tavares told French media after the merger. \"Thus, we will not need to call on European CO2 credits and [Fiat Chrysler] will no longer have to pool with Tesla or anyone.\"</p>\n<p><b>Already Anticipated?</b></p>\n<p>To be sure, the looming threat of regulatory credit sales eroding is by no means a novel development. CFO Zachary Kirkhorn noted in a call with analysts in mid-2020 that “we don’t manage the business with the assumption that regulatory credits will contribute significantly to the future. Eventually this will reduce.”</p>\n<p>Kirkhorn’s focus on the core business, especially in terms of battery technology, rather than the regulatory credit sales, is bolstered by the thoughts of prominent Tesla bulls.</p>\n<p>“We have owned Tesla for a decade and from day one we expected regulatory credits to go to zero within three years,” Jennison Associates analyst Owuraka Koney said. “They are comfortable without these regulatory credits and they make money when you exclude these credits and these non-recurring costs that they face.”</p>\n<p>Koney cited Elon Musk’smassive compensation packagetied to the company's recent stock surges as a key non-recurring cost in this context. Further, Koney argued that the regulatory credit benefits are being unfairly compared to overall profitability, which he sees as an apples-and-oranges comparison. He explained that the more relevant comparison is to Tesla’s operating income, which was $1.99 billion on a GAAP basis in 2020, up over $2 billion from the figure in 2019. The leap suggests strength greater than that simply achieved via the regulatory credit benefit, in his view.</p>\n<p>Mike Dovororany, VP of Automotive &amp; Mobility at market research firm Escalent, seconded the rosier view held by Koney, reiterating that the risk of regulatory credits fading is well understood by savvy investors, and further that the current U.S. administration might actually aid Tesla’s ability to capitalize on regulation.</p>\n<p>“Because credit sales have always been the main driver behind Tesla’s profitability, investors should be well-accustomed to this risk,” he explained. “Also, as the Biden Administration looks to reconsider stricter emissions regulations, the EV credit market could become more important than ever.”</p>\n<p>With the administration now proposing a $174-billion investment in the electric vehicle market aspart of the American Jobs Act, including new tax credits, there is certainly ample reason to be excited. Given Tesla's ability to capitalize on these incentives, it will be worth watching what the final bill entails when it crosses Biden's desk and whether it might mean lead to more big profits for Tesla.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla’s Profitability and the Surprising Thing That Could Threaten It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla’s Profitability and the Surprising Thing That Could Threaten It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n\nThe explosion in electric vehicle (EV) demand has ...</p>\n\n<a href=\"https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100861051","content_text":"Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n\nThe explosion in electric vehicle (EV) demand has served to vindicate the vision of Tesla’s (TSLA) -Get Report celebrity CEO Elon Musk. Indeed, the surge in demand for EVs has not only vindicated his foresight, but allowed his company to remain a market leader above late-coming competitors.\nHowever, while the company Musk leads as Technoking is no doubt a market leader, it has not solely cashed in by beating its competitors in terms of sales. Instead, a key to the company's recent turn to profitability has come from taking advantage of government incentives and selling the excess incentives it holds to these very same competitors. And now that many of these competitors are engaging more aggressively in EVs themselves, Tesla may soon find itself without many of these customers and, therefore, without a significant contributor to its profits.\nRaking in the Regulatory Credits\nThe credits that Tesla has handsomely profited from are tradable credits offered by various governments around the world for zero-emission vehicles. The fact that they are tradable is crucial since this allows Tesla to sell the credits to other automakers who might not otherwise comply with emission standards without the use of these credits. The set-up allows Tesla to book the credits as purely additive to its top line, with the automakers buying these credits avoiding hefty fines from regulators.\nPer Tesla’s most recent 10-K filing, the company earned $1.58 billion from the sale of these credits in 2020, up from $594 million in the year prior and $419 million in 2018. The year-over -year jump notwithstanding, the credit sales might appear to be a paltry sum given the company’s $31.5 billion in total revenue in 2020. However, their nature as purely profit, in contrast to capital intensive auto manufacturing, means they have been a pivotal part of Tesla’s push towards profitability.\nIndeed, Tesla’s much-lauded $721 million profit in 2020, the very first profitable full year in its history, was clearly boosted over the top by the surge in regulatory credit sales. Had they remained consistent with the prior periods, the landmark year would have been left short of break-even, keeping up the company's trend of annual losses maintained since its inception.\nThe trend has continued into 2021 as the company reported $518 million in revenues from credit salesin the first quarter, which boosted the company once again to a $438-million quarterly profit. While vehicle deliveries consistently catch the headlines, it's clear that the regulatory credits are buoying the automaker into the black.\nCompetition Cuts Into Cash Flow\nThe problem with the profit margin may be approaching faster than some have anticipated as well, with the increased entry of traditional automakers like Ford (F) -Get Report, General Motors (GM) -Get Report, and Stellantis STLA into the EV space.\nWhile much of the focus revolves around these companies’ threat to Tesla’s core auto sales, the popularity of Tesla among its devoted fans might sustain it amidst the hard-charging competition. As such, the trajectory of its sales, while now threatened by competent competition, remains somewhat murky at the moment.\nThe question of regulatory credit impact is much more straightforward. If Tesla’s competitors are producing their own electric vehicles and fewer ICE autos, they have no need to spend so substantially on buying credits from Tesla.\nPer a Reuters report, Fiat Chrysler agreed to purchase $2.4 billion worth of emissions credits from Tesla from 2019 through 2021, likely accounting for a lion’s share of the roughly $2.2 billion recorded in total in credits sold in Tesla’s 2019 and 2020 10-K filings. However, after Fiat Chrysler merged with French automaker PSA Group in May to form Stellantis, this reliable revenue stream looks likely to fade.\n\"With the electrical technology that PSA brought to Stellantis, we will autonomously meet carbon dioxide emission regulations as early as this year,\" Stellantis CEO Carlos Tavares told French media after the merger. \"Thus, we will not need to call on European CO2 credits and [Fiat Chrysler] will no longer have to pool with Tesla or anyone.\"\nAlready Anticipated?\nTo be sure, the looming threat of regulatory credit sales eroding is by no means a novel development. CFO Zachary Kirkhorn noted in a call with analysts in mid-2020 that “we don’t manage the business with the assumption that regulatory credits will contribute significantly to the future. Eventually this will reduce.”\nKirkhorn’s focus on the core business, especially in terms of battery technology, rather than the regulatory credit sales, is bolstered by the thoughts of prominent Tesla bulls.\n“We have owned Tesla for a decade and from day one we expected regulatory credits to go to zero within three years,” Jennison Associates analyst Owuraka Koney said. “They are comfortable without these regulatory credits and they make money when you exclude these credits and these non-recurring costs that they face.”\nKoney cited Elon Musk’smassive compensation packagetied to the company's recent stock surges as a key non-recurring cost in this context. Further, Koney argued that the regulatory credit benefits are being unfairly compared to overall profitability, which he sees as an apples-and-oranges comparison. He explained that the more relevant comparison is to Tesla’s operating income, which was $1.99 billion on a GAAP basis in 2020, up over $2 billion from the figure in 2019. The leap suggests strength greater than that simply achieved via the regulatory credit benefit, in his view.\nMike Dovororany, VP of Automotive & Mobility at market research firm Escalent, seconded the rosier view held by Koney, reiterating that the risk of regulatory credits fading is well understood by savvy investors, and further that the current U.S. administration might actually aid Tesla’s ability to capitalize on regulation.\n“Because credit sales have always been the main driver behind Tesla’s profitability, investors should be well-accustomed to this risk,” he explained. “Also, as the Biden Administration looks to reconsider stricter emissions regulations, the EV credit market could become more important than ever.”\nWith the administration now proposing a $174-billion investment in the electric vehicle market aspart of the American Jobs Act, including new tax credits, there is certainly ample reason to be excited. Given Tesla's ability to capitalize on these incentives, it will be worth watching what the final bill entails when it crosses Biden's desk and whether it might mean lead to more big profits for Tesla.","news_type":1},"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120601405,"gmtCreate":1624320411307,"gmtModify":1703833265536,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"haha","listText":"haha","text":"haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120601405","repostId":"2145031425","repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583568085402852","authorId":"3583568085402852","name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3583568085402852","authorIdStr":"3583568085402852"},"content":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","html":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120609899,"gmtCreate":1624320350411,"gmtModify":1703833262274,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120609899","repostId":"2145031425","repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":120601405,"gmtCreate":1624320411307,"gmtModify":1703833265536,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"haha","listText":"haha","text":"haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/120601405","repostId":"2145031425","repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583568085402852","authorId":"3583568085402852","name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3583568085402852","authorIdStr":"3583568085402852"},"content":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.","html":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120695608,"gmtCreate":1624320791604,"gmtModify":1703833284937,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"&nbsp;ok","listText":"&nbsp;ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120695608","repostId":"1164927223","repostType":4,"isVote":1,"tweetType":1,"viewCount":142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123116243,"gmtCreate":1624411938882,"gmtModify":1703835852642,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/123116243","repostId":"1160611217","repostType":4,"repost":{"id":"1160611217","pubTimestamp":1624409852,"share":"https://ttm.financial/m/news/1160611217?lang=&edition=fundamental","pubTime":"2021-06-23 08:57","market":"us","language":"en","title":"Peloton reportedly venturing into wearables market with digital heart rate armband","url":"https://stock-news.laohu8.com/highlight/detail?id=1160611217","media":"CNBC","summary":"Peloton is venturing into the wearables market by working on a digital heart rate armband,according ","content":"<div>\n<p>Peloton is venturing into the wearables market by working on a digital heart rate armband,according to a Bloomberg News report.\nStill-confidential details and images of the armband device, which were ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/22/peloton-getting-into-wearables-market-with-heart-rate-armband-report.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peloton reportedly venturing into wearables market with digital heart rate armband</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton reportedly venturing into wearables market with digital heart rate armband\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/22/peloton-getting-into-wearables-market-with-heart-rate-armband-report.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Peloton is venturing into the wearables market by working on a digital heart rate armband,according to a Bloomberg News report.\nStill-confidential details and images of the armband device, which were ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/22/peloton-getting-into-wearables-market-with-heart-rate-armband-report.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc."},"source_url":"https://www.cnbc.com/2021/06/22/peloton-getting-into-wearables-market-with-heart-rate-armband-report.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1160611217","content_text":"Peloton is venturing into the wearables market by working on a digital heart rate armband,according to a Bloomberg News report.\nStill-confidential details and images of the armband device, which were reviewed by Bloomberg, show that the band would come in two different sizes and pair wirelessly with Peloton's cycles and treadmills, in addition to phones, tablets and televisions that use the company's workout app.\nA Peloton spokesperson told CNBC in an emailed statement that the company's research and development team is \"always working on ideas, and we have no updates to announce at this time.\"\nPeloton had already hinted at its ambitions to expand beyond at-home fitness equipment and into wearables, rivaling the likes ofAppleWatch andFitbit. It acquiredAtlas Wearables, maker of a heart rate tracking fitness wearable, for an undisclosed amount earlier this year. Peloton also currently sells a $49 heart rate monitor that users can strap to their chest.\nAccording to Bloomberg, the new heart rate band would be able to track the intensity of users' workouts, with a small screen that shows battery levels and other features.\nIt's unclear when the band would go on sale, or if Peloton would even launch it.\nEarlier Tuesday,Peloton announced the debut of a corporate wellness programas it aims to reach new users and grow its membership base. Some investors are worried that demand for its products will wane, especially as people head back to gyms.Businesses that sign up for the new program will be able to offer their employees subsidized access to Peloton's digital fitness membership and its Bike, Bike+ and treadmills.\nPeloton shares were up more than 7% by Tuesday afternoon. The stock has fallen more than 24% year to date.","news_type":1},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121706702,"gmtCreate":1624491518006,"gmtModify":1703838063379,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"Yes&nbsp;","listText":"Yes&nbsp;","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121706702","repostId":"1167125957","repostType":4,"repost":{"id":"1167125957","pubTimestamp":1624491048,"share":"https://ttm.financial/m/news/1167125957?lang=&edition=fundamental","pubTime":"2021-06-24 07:30","market":"us","language":"en","title":"The Fed doesn't need to worry about the hot housing market right now, Jim Cramer says","url":"https://stock-news.laohu8.com/highlight/detail?id=1167125957","media":"CNBC","summary":"The Federal Reserve doesn't need to try to cool down the hot U.S. housing market with higher rates, ","content":"<div>\n<p>The Federal Reserve doesn't need to try to cool down the hot U.S. housing market with higher rates, even as home prices keep rising, CNBC's Jim Cramer said Wednesday.\n\"I don't want to repeat the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/23/jim-cramer-fed-rate-hike-wont-fix-supply-issues-in-housing-market.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Fed doesn't need to worry about the hot housing market right now, Jim Cramer says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Fed doesn't need to worry about the hot housing market right now, Jim Cramer says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/23/jim-cramer-fed-rate-hike-wont-fix-supply-issues-in-housing-market.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve doesn't need to try to cool down the hot U.S. housing market with higher rates, even as home prices keep rising, CNBC's Jim Cramer said Wednesday.\n\"I don't want to repeat the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/23/jim-cramer-fed-rate-hike-wont-fix-supply-issues-in-housing-market.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HD":"家得宝"},"source_url":"https://www.cnbc.com/2021/06/23/jim-cramer-fed-rate-hike-wont-fix-supply-issues-in-housing-market.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1167125957","content_text":"The Federal Reserve doesn't need to try to cool down the hot U.S. housing market with higher rates, even as home prices keep rising, CNBC's Jim Cramer said Wednesday.\n\"I don't want to repeat the mistakes that led to the financial crisis,\" the \"Mad Money\" host said. \"Unlike the lead-up to the great recession, homebuyers are actually solvent right now with excellent credit and strong stock portfolios.\"\nIn the lead-up to the financial crisis, regulators failed to enforce lending standards as buyers became overleveraged on their purchases, Cramer said. The Fed then stepped in to cool down the market by jacking up the federal funds rate more than a dozen times.\nBut Cramer pointed out that lending standards are more stringent now, and low mortgage rates coupled with pandemic lockdowns spurred a frenzy in homebuying. Millennials have emerged as the largest cohort of buyers on the market after years of delaying homeownership for various reasons — including the impact of the 2008 financial crisis — he added.\nCramer also noted that the real estate market — known for being cyclical in nature — has turned into a secular growth story amid low borrowing rates, sparse inventory and pent-up demand from millennial buyers.\n\"The Fed can try to slam the brakes on the economy by raising interest rates, but millennials have been stuck living in their parents' basements for years,\" he said. \"After a decade getting over the financial crisis, they've finally got the capital to buy their own homes.\"\nThe median selling price of a home in the U.S. for the first time rose above $350,000 in May, up almost 25% from a year ago, according to the National Association of Realtors.\nEconomists have associated the surging costs to purchase a home with the low supply of existing homes on the market. Meanwhile, homebuilders like Toll Brothers think it will take years before supply meets demand.","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120698457,"gmtCreate":1624320707679,"gmtModify":1703833281698,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120698457","repostId":"1100861051","repostType":4,"repost":{"id":"1100861051","pubTimestamp":1624280482,"share":"https://ttm.financial/m/news/1100861051?lang=&edition=fundamental","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"Tesla’s Profitability and the Surprising Thing That Could Threaten It","url":"https://stock-news.laohu8.com/highlight/detail?id=1100861051","media":"The Street","summary":"Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, ","content":"<blockquote>\n Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n</blockquote>\n<p>The explosion in electric vehicle (EV) demand has served to vindicate the vision of Tesla’s&nbsp;(<b>TSLA</b>) -Get Report&nbsp;celebrity CEO Elon Musk. Indeed, the surge in demand for EVs has not only vindicated his foresight, but allowed his company to remain a market leader above late-coming competitors.</p>\n<p>However, while the company Musk leads as Technoking is no doubt a market leader, it has not solely cashed in by beating its competitors in terms of sales. Instead, a key to the company's recent turn to profitability has come from taking advantage of government incentives and selling the excess incentives it holds to these very same competitors. And now that many of these competitors are engaging more aggressively in EVs themselves, Tesla may soon find itself without many of these customers and, therefore, without a significant contributor to its profits.</p>\n<p><b>Raking in the Regulatory Credits</b></p>\n<p>The credits that Tesla has handsomely profited from are tradable credits offered by various governments around the world for zero-emission vehicles. The fact that they are tradable is crucial since this allows Tesla to sell the credits to other automakers who might not otherwise comply with emission standards without the use of these credits. The set-up allows Tesla to book the credits as purely additive to its top line, with the automakers buying these credits avoiding hefty fines from regulators.</p>\n<p>Per Tesla’s most recent 10-K filing, the company earned $1.58 billion from the sale of these credits in 2020, up from $594 million in the year prior and $419 million in 2018. The year-over -year jump notwithstanding, the credit sales might appear to be a paltry sum given the company’s $31.5 billion in total revenue in 2020. However, their nature as purely profit, in contrast to capital intensive auto manufacturing, means they have been a pivotal part of Tesla’s push towards profitability.</p>\n<p>Indeed, Tesla’s much-lauded $721 million profit in 2020, the very first profitable full year in its history, was clearly boosted over the top by the surge in regulatory credit sales. Had they remained consistent with the prior periods, the landmark year would have been left short of break-even, keeping up the company's trend of annual losses maintained since its inception.</p>\n<p>The trend has continued into 2021 as the company reported $518 million in revenues from credit salesin the first quarter, which boosted the company once again to a $438-million quarterly profit. While vehicle deliveries consistently catch the headlines, it's clear that the regulatory credits are buoying the automaker into the black.</p>\n<p><b>Competition Cuts Into Cash Flow</b></p>\n<p>The problem with the profit margin may be approaching faster than some have anticipated as well, with the increased entry of traditional automakers like Ford&nbsp;(<b>F</b>) -Get Report, General Motors&nbsp;(<b>GM</b>) -Get Report, and Stellantis STLA into the EV space.</p>\n<p>While much of the focus revolves around these companies’ threat to Tesla’s core auto sales, the popularity of Tesla among its devoted fans might sustain it amidst the hard-charging competition. As such, the trajectory of its sales, while now threatened by competent competition, remains somewhat murky at the moment.</p>\n<p>The question of regulatory credit impact is much more straightforward. If Tesla’s competitors are producing their own electric vehicles and fewer ICE autos, they have no need to spend so substantially on buying credits from Tesla.</p>\n<p>Per a Reuters report, Fiat Chrysler agreed to purchase $2.4 billion worth of emissions credits from Tesla from 2019 through 2021, likely accounting for a lion’s share of the roughly $2.2 billion recorded in total in credits sold in Tesla’s 2019 and 2020 10-K filings. However, after Fiat Chrysler merged with French automaker PSA Group in May to form Stellantis, this reliable revenue stream looks likely to fade.</p>\n<p>\"With the electrical technology that PSA brought to Stellantis, we will autonomously meet carbon dioxide emission regulations as early as this year,\" Stellantis CEO Carlos Tavares told French media after the merger. \"Thus, we will not need to call on European CO2 credits and [Fiat Chrysler] will no longer have to pool with Tesla or anyone.\"</p>\n<p><b>Already Anticipated?</b></p>\n<p>To be sure, the looming threat of regulatory credit sales eroding is by no means a novel development. CFO Zachary Kirkhorn noted in a call with analysts in mid-2020 that “we don’t manage the business with the assumption that regulatory credits will contribute significantly to the future. Eventually this will reduce.”</p>\n<p>Kirkhorn’s focus on the core business, especially in terms of battery technology, rather than the regulatory credit sales, is bolstered by the thoughts of prominent Tesla bulls.</p>\n<p>“We have owned Tesla for a decade and from day one we expected regulatory credits to go to zero within three years,” Jennison Associates analyst Owuraka Koney said. “They are comfortable without these regulatory credits and they make money when you exclude these credits and these non-recurring costs that they face.”</p>\n<p>Koney cited Elon Musk’smassive compensation packagetied to the company's recent stock surges as a key non-recurring cost in this context. Further, Koney argued that the regulatory credit benefits are being unfairly compared to overall profitability, which he sees as an apples-and-oranges comparison. He explained that the more relevant comparison is to Tesla’s operating income, which was $1.99 billion on a GAAP basis in 2020, up over $2 billion from the figure in 2019. The leap suggests strength greater than that simply achieved via the regulatory credit benefit, in his view.</p>\n<p>Mike Dovororany, VP of Automotive &amp; Mobility at market research firm Escalent, seconded the rosier view held by Koney, reiterating that the risk of regulatory credits fading is well understood by savvy investors, and further that the current U.S. administration might actually aid Tesla’s ability to capitalize on regulation.</p>\n<p>“Because credit sales have always been the main driver behind Tesla’s profitability, investors should be well-accustomed to this risk,” he explained. “Also, as the Biden Administration looks to reconsider stricter emissions regulations, the EV credit market could become more important than ever.”</p>\n<p>With the administration now proposing a $174-billion investment in the electric vehicle market aspart of the American Jobs Act, including new tax credits, there is certainly ample reason to be excited. Given Tesla's ability to capitalize on these incentives, it will be worth watching what the final bill entails when it crosses Biden's desk and whether it might mean lead to more big profits for Tesla.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla’s Profitability and the Surprising Thing That Could Threaten It</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla’s Profitability and the Surprising Thing That Could Threaten It\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n\nThe explosion in electric vehicle (EV) demand has ...</p>\n\n<a href=\"https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/investing/surprising-thing-that-could-threaten-teslas-profitability","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100861051","content_text":"Rising competition in the electric vehicle space could not only put a crimp in Tesla’s growth rate, but diminish a big source of income as well.\n\nThe explosion in electric vehicle (EV) demand has served to vindicate the vision of Tesla’s (TSLA) -Get Report celebrity CEO Elon Musk. Indeed, the surge in demand for EVs has not only vindicated his foresight, but allowed his company to remain a market leader above late-coming competitors.\nHowever, while the company Musk leads as Technoking is no doubt a market leader, it has not solely cashed in by beating its competitors in terms of sales. Instead, a key to the company's recent turn to profitability has come from taking advantage of government incentives and selling the excess incentives it holds to these very same competitors. And now that many of these competitors are engaging more aggressively in EVs themselves, Tesla may soon find itself without many of these customers and, therefore, without a significant contributor to its profits.\nRaking in the Regulatory Credits\nThe credits that Tesla has handsomely profited from are tradable credits offered by various governments around the world for zero-emission vehicles. The fact that they are tradable is crucial since this allows Tesla to sell the credits to other automakers who might not otherwise comply with emission standards without the use of these credits. The set-up allows Tesla to book the credits as purely additive to its top line, with the automakers buying these credits avoiding hefty fines from regulators.\nPer Tesla’s most recent 10-K filing, the company earned $1.58 billion from the sale of these credits in 2020, up from $594 million in the year prior and $419 million in 2018. The year-over -year jump notwithstanding, the credit sales might appear to be a paltry sum given the company’s $31.5 billion in total revenue in 2020. However, their nature as purely profit, in contrast to capital intensive auto manufacturing, means they have been a pivotal part of Tesla’s push towards profitability.\nIndeed, Tesla’s much-lauded $721 million profit in 2020, the very first profitable full year in its history, was clearly boosted over the top by the surge in regulatory credit sales. Had they remained consistent with the prior periods, the landmark year would have been left short of break-even, keeping up the company's trend of annual losses maintained since its inception.\nThe trend has continued into 2021 as the company reported $518 million in revenues from credit salesin the first quarter, which boosted the company once again to a $438-million quarterly profit. While vehicle deliveries consistently catch the headlines, it's clear that the regulatory credits are buoying the automaker into the black.\nCompetition Cuts Into Cash Flow\nThe problem with the profit margin may be approaching faster than some have anticipated as well, with the increased entry of traditional automakers like Ford (F) -Get Report, General Motors (GM) -Get Report, and Stellantis STLA into the EV space.\nWhile much of the focus revolves around these companies’ threat to Tesla’s core auto sales, the popularity of Tesla among its devoted fans might sustain it amidst the hard-charging competition. As such, the trajectory of its sales, while now threatened by competent competition, remains somewhat murky at the moment.\nThe question of regulatory credit impact is much more straightforward. If Tesla’s competitors are producing their own electric vehicles and fewer ICE autos, they have no need to spend so substantially on buying credits from Tesla.\nPer a Reuters report, Fiat Chrysler agreed to purchase $2.4 billion worth of emissions credits from Tesla from 2019 through 2021, likely accounting for a lion’s share of the roughly $2.2 billion recorded in total in credits sold in Tesla’s 2019 and 2020 10-K filings. However, after Fiat Chrysler merged with French automaker PSA Group in May to form Stellantis, this reliable revenue stream looks likely to fade.\n\"With the electrical technology that PSA brought to Stellantis, we will autonomously meet carbon dioxide emission regulations as early as this year,\" Stellantis CEO Carlos Tavares told French media after the merger. \"Thus, we will not need to call on European CO2 credits and [Fiat Chrysler] will no longer have to pool with Tesla or anyone.\"\nAlready Anticipated?\nTo be sure, the looming threat of regulatory credit sales eroding is by no means a novel development. CFO Zachary Kirkhorn noted in a call with analysts in mid-2020 that “we don’t manage the business with the assumption that regulatory credits will contribute significantly to the future. Eventually this will reduce.”\nKirkhorn’s focus on the core business, especially in terms of battery technology, rather than the regulatory credit sales, is bolstered by the thoughts of prominent Tesla bulls.\n“We have owned Tesla for a decade and from day one we expected regulatory credits to go to zero within three years,” Jennison Associates analyst Owuraka Koney said. “They are comfortable without these regulatory credits and they make money when you exclude these credits and these non-recurring costs that they face.”\nKoney cited Elon Musk’smassive compensation packagetied to the company's recent stock surges as a key non-recurring cost in this context. Further, Koney argued that the regulatory credit benefits are being unfairly compared to overall profitability, which he sees as an apples-and-oranges comparison. He explained that the more relevant comparison is to Tesla’s operating income, which was $1.99 billion on a GAAP basis in 2020, up over $2 billion from the figure in 2019. The leap suggests strength greater than that simply achieved via the regulatory credit benefit, in his view.\nMike Dovororany, VP of Automotive & Mobility at market research firm Escalent, seconded the rosier view held by Koney, reiterating that the risk of regulatory credits fading is well understood by savvy investors, and further that the current U.S. administration might actually aid Tesla’s ability to capitalize on regulation.\n“Because credit sales have always been the main driver behind Tesla’s profitability, investors should be well-accustomed to this risk,” he explained. “Also, as the Biden Administration looks to reconsider stricter emissions regulations, the EV credit market could become more important than ever.”\nWith the administration now proposing a $174-billion investment in the electric vehicle market aspart of the American Jobs Act, including new tax credits, there is certainly ample reason to be excited. Given Tesla's ability to capitalize on these incentives, it will be worth watching what the final bill entails when it crosses Biden's desk and whether it might mean lead to more big profits for Tesla.","news_type":1},"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120609899,"gmtCreate":1624320350411,"gmtModify":1703833262274,"author":{"id":"3585969981658298","authorId":"3585969981658298","name":"Claireeeee","avatar":"https://static.tigerbbs.com/8210c79a75f0858c29063909c70e422d","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585969981658298","authorIdStr":"3585969981658298"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120609899","repostId":"2145031425","repostType":4,"repost":{"id":"2145031425","pubTimestamp":1624318087,"share":"https://ttm.financial/m/news/2145031425?lang=&edition=fundamental","pubTime":"2021-06-22 07:28","market":"us","language":"en","title":"Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2145031425","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid pl","content":"<p><img src=\"https://static.tigerbbs.com/b52e3a034da672fc03c5d547be4af2e5\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA)&nbsp;will be adding two new production lines&nbsp;at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.</li>\n <li>The company is getting <a href=\"https://laohu8.com/S/AONE\">one</a> new line up and running by fall and the other by early 2022.</li>\n <li>The additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.</li>\n <li>Moderna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.</li>\n <li>Company officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.</li>\n <li>Citing FactSet,&nbsp;Wall Street Journal posted&nbsp;that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.</li>\n <li>The company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.</li>\n <li>Moderna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.</li>\n <li>The company said earlier this week it had agreed to provide the U.S. an&nbsp;additional 200 million doses&nbsp;starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.</li>\n <li><b>Price Action:</b>&nbsp;MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 07:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-plans-expand-covid-19-190507394.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145031425","content_text":"Moderna Inc (NASDAQ: MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19 vaccine to prepare for making booster shots.\nThe company is getting one new line up and running by fall and the other by early 2022.\nThe additions will help Moderna increase its overall production capacity by 50% at its plant in the Boston suburb of Norwood.\nModerna and its manufacturing partners are also expanding production capacity outside the U.S., aiming to roughly triple the annual global output of COVID-19 vaccine doses to about 3 billion in 2022 from as many as 1 billion this year.\nCompany officials said the latest expansion would help Moderna boost its overall supply of COVID-19 vaccine doses to the U.S. and other countries.\nCiting FactSet, Wall Street Journal posted that Moderna’s COVID-19 vaccine sales will top $17.1 billion this year, dip slightly to $16.8 billion in 2022 and come in at $7.4 billion in 2023.\nThe company currently makes between 40 million to 50 million doses a month in the U.S., most of which is made at the Norwood plant, but some are made at a contractor’s plant in New Hampshire, WSJ noted.\nModerna has been on a hiring spree. Last year, the company added nearly 500 employees, boosting its workforce to 1,300.\nThe company said earlier this week it had agreed to provide the U.S. an additional 200 million doses starting later this year, over an above 300 million Moderna expects it will have delivered for U.S. use by the end of July.\nPrice Action: MRNA shares are up 4.86% at $208.87 during the market trading session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}